4Tissue is a research and clinical development firm that develops solutions to solve the limitations of cell-based therapies.
4Tissue has raised $7.9M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
4Tissue's investors include Virginie Saverys, Annemie Van de Casteele, Griet Nuytinck.
4Tissue is headquartered in Ghent, Belgium.
4Tissue is a research and clinical development firm that develops solutions to solve the limitations of cell-based therapies.
4Tissue is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"4Tissue — Funding & Investors." VCBacked, October 20, 2026, https://www.vcbacked.co/company/4tissue. Accessed November 15, 2026.
VCBacked. (2026). 4Tissue — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/4tissue
{{cite web |title=4Tissue — Funding & Investors |url=https://www.vcbacked.co/company/4tissue |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at 4Tissue? Request a listing update